Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
22.39%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 5.29Close
$ 1.96 - $ 5.29 52-Week Range
Ticker Information
Ticker
IMDXCompany Name
INSIGHT MOLECULAR DIAGNOSTICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQINSIGHT MOLECULAR DIAGNOSTICS INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IMDX - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 953K | 22.39% | $ 4.26M |
| 3/31/2025 | $ 795K | 20.69% | $ 3.84M |
| 12/31/2024 | $ 512K | 27.22% | $ 1.88M |
| 9/30/2024 | $ 566K | 79.83% | $ 709K |
| 6/30/2024 | $ 265K | 25.9% | $ 1.02M |
| 3/31/2024 | $ -49K | 0% | $ 1.38M |
| 12/31/2023 | $ -73K | 0% | $ 1.5M |
| 9/30/2023 | $ 465K | 0% | $ -2.36M |
| 6/30/2023 | $ 1.54M | 0% | $ -1.77M |
| 3/31/2023 | $ 2.78M | 0% | $ -169K |
Key Performance Insights, Last 5 Years
- INSIGHT MOLECULAR DIAGNOSTICS INC's latest trailing twelve months (TTM) CapEx % stands at 274.65%.
- Over the past 5 years, INSIGHT MOLECULAR DIAGNOSTICS INC's average CapEx % has been 89.58%.
- The median CapEx % for INSIGHT MOLECULAR DIAGNOSTICS INC during this period was 43.35%
- INSIGHT MOLECULAR DIAGNOSTICS INC reached its highest CapEx % over the past 5 years at 453.03%.
- The lowest CapEx % recorded by INSIGHT MOLECULAR DIAGNOSTICS INC in the same timeframe 20.69%
INSIGHT MOLECULAR DIAGNOSTICS INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for INSIGHT MOLECULAR DIAGNOSTICS INC is calculated as follows: CapEx [ $ 1.96M ] / Revenues [ $ 714K ]
(=) CapEx % [ 274.65% ] IMDX - Capital Expenditures Margin, Last 5 years
20.69%
Minimum
Mar 31, 2025
453.03%
Maximum
Dec 31, 2022
89.58%
Average
43.35%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |